David N. Hager

Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020

Mark W. Tenforde, Sara Kim, Christopher J. Lindsell et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 1.4K citations · Full text

Veterinary Medicine, Infectious Diseases, Clinical Epidemiology +16

Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity

Mark W. Tenforde, Wesley H. Self, Katherine Adams et al. · JAMA · 2021 · 681 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

Adam S. Lauring, Mark W. Tenforde, James D. Chappell et al. · BMJ · 2022 · 681 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A targeted real-time early warning score (TREWScore) for septic shock

Katharine E. Henry, David N. Hager, Peter J. Pronovost et al. · Science Translational Medicine · 2015 · 600 citations

Veterinary Medicine, Emergency Medicine, Internal Medicine +17

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

Wesley H. Self, Mark W. Tenforde, Jillian P. Rhoads et al. · MMWR Morbidity and Mortality Weekly Report · 2021 · 455 citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +16